Amino acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy

Pharmacotherapy

Volumn 28, Issue 5 PART 1, 2008, Pages 600-613

  Btaiche, Imad F ^a,b   Mohammad, Rima A ^c   Alaniz, Cesar ^a,b   Mueller, Bruce A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^c LONG ISLAND UNIVERSITY   (United States)

Author keywords

Acute kidney injury; Amino acids; Continuous renal replacement therapy; Critical illness; CRRT; Nutrition; Renal failure

Indexed keywords

AMINO ACID; GLUTAMINE;

BODY MASS; CATABOLISM; CLINICAL TRIAL; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICAL ILLNESS; DRUG SAFETY; ELECTROLYTE DISTURBANCE; ENTERIC FEEDING; FLUID INTAKE; HEMODIALYSIS; HUMAN; KIDNEY INJURY; MALNUTRITION; METABOLIC DISORDER; MORBIDITY; MULTIPLE ORGAN FAILURE; NITROGEN BALANCE; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; REVIEW; SEPSIS; STRESS; SURVIVAL; TREATMENT OUTCOME; UREMIA;

AMINO ACIDS; CRITICAL ILLNESS; HUMANS; KIDNEY FAILURE, ACUTE; PROTEINS; RENAL REPLACEMENT THERAPY;

EID: 42949156946     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.5.600     Document Type: Review

References (82)

1. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, for the Acute Dialysis Quality Initiative Workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative group. Crit Care 2004;8:R204-12.
2. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007;35:1837-43.
3. Uchino S, Kellum JA, Bellomo R, et al, for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-18.
4. Uchino S, Bellomo R, Morimatsu H, et al, for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Continuous renal replacement therapy: a worldwide practice survey. Intensive Care Med 2007;33:1563-70.
5. Marin A, Hardy G. Practical implications of nutritional support during continuous renal replacement therapy. Curr Opin Clin Nutr Metab Care 2001;4:219-25.
6. Wooley JA, Btaiche IF, Good KL. Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 2005;20:176-91.
7. Ronco C, Cruz D, Bellomo R. Continuous renal replacement in critical illness. Contrib Nephrol 2007;156:309-19
8. Druml W. Nutritional management of acute renal failure. Am J Kidney Dis 2001;37(suppl 2):S89-94.
9. Bozfakioglu S. Nutrition in patients with acute renal failure. Nephrol Dial Transplant 2001;16:21-2.
10. Mitch WE, Chesney RW. Amino acid metabolism by the kidney. Miner Electrolyte Metab 1983;9:190-202.
11. Laidlaw SA, Kopple JD. Newer concepts of the indispensable amino acids. Am J Clin Nutr 1987;46:593-605.
12. Clowes GH, Heideman M, Lindberg B, et al. Effects of parenteral alimentation on amino acid metabolism in septic patients. Surgery 1980;88:531-43.
13. Vente JP, von Meyenfeldt MF, van Eijk HM, et al. Plasma amino acid profiles in sepsis and stress. Ann Surg 1989;209:57-62.
14. Avenell A. Glutamine in critical care: current evidence from systematic reviews. Proc Nutr Soc 2006;65:236-41.
15. Berg A, Norberg A, Martling CR, Gamrin L, Rooyackers O, Wernerman J. Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy. Intensive Care Med 2007;33:660-6.
16. Windle EM. Glutamine supplementation in critical illness: evidence, recommendations, and implications for clinical practice in burn care. J Burn Care Res 2006;27:764-72.
17. Btaiche IF, Khalidi N. Metabolic complications of parenteral nutrition in adults, part 1. Am J Health-Syst Pharm 2004;61:1938-49.
18. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006;55:3151-9.
19. Frankenfield DC, Reynolds HN. Nutritional effect of continuous hemodiafiltration. Nutrition 1995;11:388-93.
20. The National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000;35(6 suppl 2):S1-140. (Erratum in Am J Kidney Dis 2001;38:917.)
21. Dickerson RN. Using nitrogen balance in clinical practice. Hosp Pharm 2005;40:1081-5.
22. Wernerman J, von der Decken A, Vinnars E. Protein synthesis in skeletal muscle in relation to nitrogen balance after abdominal surgery: the effect of total parenteral nutrition. JPEN J Parenter Enteral Nutr 1986;10:578-82.
23. Konstantinides FN, Konstantinides NN, Li JC, Myaya ME, Cerra FB. Urinary urea nitrogen: too insensitive for calculating nitrogen balance studies in surgical clinical nutrition. JPEN J Parenter Enteral Nutr 1991;15:189-93.
24. Blumenkrantz MJ, Kopple JD, Gutman RA, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980;33:1567-85.
25. Kopple JD. Renal disorders and nutrition. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern nutrition in health and disease, 9th ed. Baltimore MD: Lippincott Williams & Wilkins;1999:1439-72.
26. Druml W. Nutritional support in acute renal failure. In: Mitch WE, Klahr S, eds. Handbook of nutrition and the kidney, 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002:191-213.
27. Clark WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994;4:1413-20.
28. Leblanc M, Garred LJ, Cardinal J, et al. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy. Am J kidney Dis 1998;32:444-53.
29. Tremblay R, Ethier J, Quérin S, Béroniade V, Falardeau P, Leblanc M. Veno-venous continuous renal replacement therapy for burned patients with acute renal failure. Burns 2000;26:638-43.
30. Chima CS, Meyer L,Hummell AC, et al. Nitrogen balance in postsurgical patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 1993;3:1516-21.
31. Fiaccadori E, Maggiore U, Rotelli C, et al. Effects of different energy intakes on nitrogen balance in palients with acute renal failure: a pilot study. Nephrol Dial Transplant 2005;20:1976-80.
32. The American Society for Parenteral and Enteral Nutrition Board of Directors and the Clinical Guidelines Task Force. Renal disease. JPEN J Parenter Enteral Nutr 2002;26:SA78-9.
33. Bellomo R, Farmer M, Bhonagiri S, et al. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control. Int J Artif Organs 1999;22:145-50.
34. Mirtallo JM, Schneider PJ, Mavko K, et al. A comparison of essential and general amino acid infusions in the nutritional support of patients with compromised renal function. JPEN J Parenter Enteral Nutr 1982;8:109-13.
35. Long CL, Jeevanandam M, Kinney JM. Metabolism and recycling of urea in man. Am J Clin Nutr 1978;31:1367-82.
36. Kopple JD, Swendseid ME. Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest 1975;55:881-9.
37. Rapp RP, Bivins BA, McRoberts JW. Hyperammonemia encephalopathy in a patient receiving essential amino acid/dextrose parenteral nutrition. Clin Pharm 1982;1:276-80.
38. Bellomo R, Mehta R. Acute renal replacement in the intensive care unit: now and tomorrow. New Horiz 1995;3:760-7.
39. Swartz RD, Bustami RT, Daley JM, Gillespie BW, Port FK. Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure. Clin Nephrol 2005;63:335-45.
40. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C, for the ADQI Workgroup. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-63.
41. Joy MS, Matzke GR, Armstrong DK, Marx MA, Zarowitz BJ. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 1998;32:362-75.
42. Clark WR, Mueller BA, Kraus MA, Macias WL. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997;8:804-12.
43. Mueller BA, Pasko DA, Sowinski KM. Higher renal replacement therapy dose delivery influences on drug therapy. Artif Organs 2003;27:806-12.
44. Druml W. Metabolic aspects of continuous renal replacement therapies. Kidney Int Suppl 1999;72:S56-61.
45. Ward RA. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application. J Am Soc Nephrol 2005;16:2421-30.
46. Mokrzycki MH, Kaplan AA. Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 1996;7:2259-63.
47. Wolfson M, Jones MR, Kopple JD. Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1982;21:500-6.
48. Hynote ED, McCamish MA, Depner TA, Davis PA. Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute renal failure. JPEN J Parenter Enteral Nutr 1995;19:15-21.
49. Navarro JF, Marcen R, Teruel JL, et al. Effect of different membranes on amino acid losses during haemodialysis. Nephrol Dial Transplant 1998;13:113-17.
50. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-7.
51. Navarro JF, Mora C, Leon C, et al. Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr 2000;71:765-73.
52. Kihara M, Ikeda Y, Fujita H, et al. Amino acid losses and nitrogen balance during slow diurnal hemodialysis in critically ill patients with renal failure. Intensive Care Med 1997;23:110-13.
53. Davenport A, Roberts NB. Amino acid losses during haemofiltration. Blood Purif 1989;7:192-6.
54. Davenport A, Roberts NB. Amino acid losses during continuous high-flux hemofiltration in the critically ill. Crit Care Med 1989;17:1010-14.
55. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000;28:1161-5.
56. Davies SP, Reaveley DA, Brown EA, Kox WJ. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med 1991;19:1510-15.
57. Frankenfield DC, Badellino MM, Reynolds HN, Wiles CE, Siegel JH, Goodarzi S. Amino acid loss and plasma concentration during continuous hemodiafiltration. JPEN J Parenter Enteral Nutr 1993;17:551-61.
58. Bellomo R, Martin H, Parkin G, Love J, Kearley Y, Boyce N. Continuous arteriovenous haemodiafiltration in the critically ill: influence on major nutrient balances. Intensive Care Med 1991;17:399-402.
59. Macias WL, Alaka KJ, Murphy MH, Miller ME, Clark WR, Mueller BA. Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. JPEN J Parenter Enteral Nutr 1996;20:56-62.
60. Scheinkestel CD, Adams F, Mahony L, et al. Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition 2003;19:733-40.
61. Scheinkestel CD, Kar L, Marshall K, et al. Prospective randomized trial to assess caloric and prolein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy. Nutrition 2003;19:909-16.
62. Bellomo R, Seacombe J, Daskalakis M, et al. A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Ren Fail 1997;19:111-20.
63. Bellomo R, Tan HK, Bhonagiri S, et al. High protein intake during continuous hemodiafiltration: impact on amino acids and nitrogen balance. Int J Artif Organs 2002;25:261-8.
64. Fiaccadori E, Lombardi M, Leonardi S, et al. Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: a prospective cohort study. J Am Soc Nephrol 1999;10:581-93.
65. Arora P, Strauss BJ, Borovnicar D, Stroud D, Atkins RC, Kerr PG. Total body nitrogen predicts long-term mortality in haemodialysis patients: a single-centre experience. Nephrol Dial Transplant 1998;13:1731-6.
66. Franz M, Hörl WH. Protein catabolism in acute renal failure. Miner Electrolyte Metab 1997;23:189-93.
67. Matthews DE. Proteins and amino acids. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern nutrition in health and disease, 9th ed. Baltimore, MD: Lippincott Williams & Wilkins;1999:11-48.
68. Raj DSC, Adeniyi O, Dominic EA, et al. Amino acid repletion does not decrease muscle protein catabolism during hemodialysis. Am J Physiol Endocrinol Metab 2007;292:E1534-42.
69. Bohé J, Rennie MJ. Muscle protein metabolism during hemodialysis. J Ren Nutr 2006;16:3-16.
70. Rennie MJ, Bohé J, Wolfe RR. Latency, duration and dose response relationships of amino acid effects on human muscle protein synthesis. J Nutr 2002;132:S3225-7.
71. Wolfe RR, Goodenough RD, Burke JF, Wolfe MH. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg 1983;197:163-71.
72. Gabbai FB, Peterson OW, Blantz RC. Glycine prevents toxic tubular cell injury. Ren Fail 1994;16:101-8.
73. Kaltenbach JP, Ganote CE, Carone FA. Renal tubular necrosis induced by compounds structurally related to D-serine. Exp Mol Pathol 1979;30:209-14.
74. Racusen LC, Whelton A, Solez K. Effects of lysine and other amino acids on kidney structure and function in the rat. Am J Pathol 1985;120:436-42.
75. Brunori G. Nutrition support in renal disease. In: Payne-James J, Grimble GK, Silk DBA, eds. Artificial nutrition support in clinical practice, 2nd ed. London: Greenwich Medical Media Limited; 2001:523-35.
76. Heyland DK. Immunonutrition in the critically ill: putting the cart before the horse? Nutr Clin Pract 2002;17:267-72.
77. Marik PE. The cardiovascular dysfunction of sepsis: a NO and L-arginine deficient state? Crit Care Med 2003;31:971-3.
78. Marik PE. Arginine: too much of a good thing may be bad! Crit Care Med 2006;34:2844-7.
79. Ochoa JB, Strange J, Kearney P, et al. Effects of L-arginine on the proliferation of T lymphocyte subpopulations. JPEN J Parenter Enteral Nutr 2001;25:23-9.
80. Schwartz IF, Schwartz D, Traskonov M, et al. L-arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats. Kidney Int 2002;62:1700-6.
81. Jerkic M, Varagic J, Jovovic D, et al. L-arginine reduces tubular cell injury in acute post-ischaemic renal failure. Nephrol Dial Transplant 1999;14:1398-407.
82. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993;92:1859-65.